By: Bridget Mulroy
When I met Mike Smilo at the opening of Archangels, I expected to hear a cancer story.
What I didn’t expect was to meet someone who described himself as lucky.
By every conventional measure, Mike should have been bitter.
His journey reads like something pulled from the pages of a medical thriller.
Months before receiving a diagnosis, he was experiencing severe pain throughout his body while preparing to welcome a newborn daughter into the world.
The symptoms were frightening but seemingly unrelated.
Shoulder pain.
Lumps.
Nosebleeds.
No one connected the dots.
Then came the diagnosis.
Stage 4 metastatic melanoma.
More than seventy tumors.
Cancer throughout his bones, lungs, liver, brain, and spinal lining.
A prognosis so grim that doctors warned his family not to spend time searching survival statistics online.
The story becomes even more staggering from there.
There were moments when Mike was told he wasn’t eligible for clinical trials.
Moments when critical genomic information remained unexplored.
Moments when opportunities appeared only because someone took a second look.
And eventually, a highly personalized engineered T-cell therapy in Germany that produced a remarkable response.
Within days, visible tumors began shrinking.
The treatment nearly cost him everything.
The immune response was so intense that Mike endured severe neurological inflammation and significant memory loss.
There were periods when he couldn’t remember his wife’s name.
Couldn’t remember how many children he had.
Couldn’t remember that he had cancer.
Most people would describe that chapter as tragic.
Mike describes it differently.
Not because he minimizes what happened.
But because he chooses to focus on what remains.
At Archangels, he looked at me and said something I wasn’t expecting.
“People often look at me and feel sorry for me because they know my diagnosis and everything my family has been through. But I honestly feel like one of the luckiest people in the world.”
I remember pausing.
Lucky?
How could someone who had lost so much possibly use that word?
Then he explained.
“I was diagnosed with a disease that should have taken my life, yet through faith, persistence, and access to information that many patients never find, I was given another chance at life.”
And suddenly it made sense.
Mike wasn’t speaking from denial.
He was speaking from a perspective.
His gratitude wasn’t rooted in what he’d endured.
It was rooted in what he’d been allowed to keep.
His wife.
His children.
His future.
His purpose.
That purpose now lives within the Smilo Foundation.
Because what haunts Mike isn’t simply the possibility that he could have died.
It’s the realization that countless patients may never discover options that could help them because they don’t have the same network, resources, or access to information.
His mission is straightforward.
Help patients understand their options.
Help families navigate complexity.
Help people feel less alone.
And remind them that one conversation should never define their entire future.
Mike’s story is extraordinary.
But the lesson he hopes people remember is remarkably simple.
Hope and realism can coexist.
Faith and science can coexist.
And information can be one of the most powerful forms of hope we have.
Disclaimer: This article is for informational and editorial purposes only. It is not intended to provide medical advice, diagnosis, treatment guidance, or a substitute for consultation with qualified healthcare professionals. Cancer treatment outcomes vary by individual, and therapies discussed in this article may not be appropriate, available, or effective for every patient. Readers should consult their physicians or medical care teams before making any healthcare decisions. References to Mike Smilo’s personal experience, the Smilo Foundation, or related platforms are included for storytelling and informational context and should not be interpreted as medical endorsement or treatment recommendation.
